JESSICA CARRINGER: Open Payments
NPI 1952793978 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,416 in 110 payments from 30 companies in 2025. Trend: 2023 $2,018 · 2024 $1,811 · 2025 $2,416
Food & beverage: $2,341Consulting: $75
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $269 |
| E.R. Squibb & Sons, L.L.C. | 11 | $198 |
| AstraZeneca Pharmaceuticals LP | 7 | $187 |
| Incyte Corporation | 8 | $183 |
| Aveo Pharmaceuticals, Inc. | 4 | $147 |
| Janssen Biotech, Inc. | 7 | $145 |
| Regeneron Healthcare Solutions, Inc. | 5 | $113 |
| Lilly USA, LLC | 6 | $111 |
| ABBVIE INC. | 5 | $92 |
| GENZYME CORPORATION | 3 | $85 |
Products named: OPDIVO, KISQALI, FOTIVDA, MONJUVI, VERZENIO, QINLOCK, LYNOZYFIC, JAKAFI.
Industry payments across TN — which companies pay providers there.
